Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses the main challenges, primarily bleeding, practitioners face when treating acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). Most patients present severe bleeding, primarily intracranial bleeding. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
The main challenges facing practitioners treating APL
